1.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 and under Sponsor: NCI, Other Protocol IDs: AML08, 5R01CA138744, 1R01CA115422, NCT00703820
|
|
2.
|
Phase: Phase II Type: Treatment Status: Active Age: 8 to 75 Sponsor: NHLBI Protocol IDs: 090087, 09-H-0087, NCT00859586
|
|
3.
|
Phase: Phase II Type: Treatment Status: Active Age: 10 and over Sponsor: Other Protocol IDs: 2010-0981, NCT01409161
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: Over 12 months to 21 Sponsor: NCI, Other Protocol IDs: CDR0000680970, COG-ADVL1011, ADVL1011, NCT01164163
|
|
5.
|
Phase: No phase specified Type: Treatment Status: Active Age: Under 70 Sponsor: NCI, Other Protocol IDs: CDR0000518230, P30CA022453, WSU-2006-059, WSU-112506MP2F, NCT00423826
|